Executives

Career

• Dr. Dong-Hyun Son has gained experience in various fields, including the multinational pharmaceutical company Rp Scherer Korea (now Catalent Inc.), the foreign analysis and diagnostic company Foss Analytical, and domestic venture companies. Through this experience, he has a deep understanding of technology development, product development, and full-cycle technology commercialization.

• Dr. Dong-Hyun Son majored in biotechnology and molecular biotechnology at Korea University, received his doctorate, and published four SCIE papers. He has also performed sales and marketing work at several bio-related companies, so he is well-versed in market trends and has extensive experience in the elements required for technology to succeed in the market.

• Based on this academic background and practical experience, he has a deep understanding of product development, marketability, business feasibility, and technology analysis through technology commercialization, and seeks to optimize the technological requirements of big pharma’s demand companies and promote successful technology commercialization, thereby providing differentiated value in the bio/new drug field.

• Doctor of Philosophy - PhD, Biotechnology, Korea University

• Masters for Biotechnology, Korea University

• Postdoctoral Researcher, Department of Life Sciences, Korea University